Friedl A, et al. - As a part of this study, experts resolved to scrutinize the diagnostic performance and complication rate of the in-bore magnetic resonance imaging-guided transrectal targeted prostate biopsy (MRGB) in patients with a history of previous biopsies and persistent suspicion of prostate cancer. A sufficient diagnostic performance of MRGB was illustrated in the identification of clinically significant prostate cancer (csPCa) in prostate imaging reporting and data system (PI-RADS) 3-5 lesions with low complication rate. The observations made were as follows: The skill of biopsy taking was acquired rapidly and location of index lesion did not influence the cancer detection rate (CDR).